SK Biopharmaceuticals Co., Ltd. (KOSE: A326030)
Health Care · Pharmaceuticals · KR
₩83,700.00
-4.12% today · -16.7% 1Y
SK Biopharmaceuticals Co., Ltd. (KOSE: A326030) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.73B.
Over the last twelve months the share price has lost 16.7%, trading between 73.00K and 144.10K.
Tweenvest scores SK Biopharmaceuticals Co., Ltd. across four factors: quality 73/100, value 63/100, growth 100/100. Its strongest factor is growth.
A326030 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.73B
- Revenue (TTM)
- $556.20M
- P/E
- 16.35
- EPS
- 5,119.49
- Dividend yield
- —
- Beta (5Y)
- 0.72
- 52-week high
- ₩144,100.00
- 52-week low
- ₩73,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 78.31M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.22 | -0.96% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.